Description: Grünenthal is a global leader in pain management and related diseases. Our purpose is to change lives for the better – and innovation is our passion. We focus our activities on moving towards our vision of a world free of pain.
innovation (7882) pain management (939) partnerships (291) pharmaceutical company (152) pain treatment (86) research & development (67) science-based (36) grünenthal (33) privately-owned (31) innovative treatments (17)
A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.
Annual Reports 2022/23 Explore Report PDF Grünenthal is a global leader in pain management. Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better, and innovation is our passion. We are focusing all our activities and efforts on working towards our vision of a world free
On 1 August 2023, Grünenthal announced the successful completion of the Joint Venture with Kyowa Kirin International (KKI). The Joint Venture comprises 13 brands across six therapeutic areas primarily focused on pain management, including Abstral® and PecFent® for breakthrough cancer pain, Moventig®...